Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001172661-26-000719·Deep Track Capital, LP
Schedule 13G ownership disclosure
Oruka Therapeutics Inc
Common stock, $0.001 Par Value · CUSIP: 687604108
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Deep Track Capital, LP
Shares: 2,161,510.00 · Class: 4.47%
- Deep Track Biotechnology Master Fund, Ltd.
Shares: 1,899,455.00 · Class: 3.92%
- David Kroin
Shares: 2,161,510.00 · Class: 4.47%
- Deep Track Special Opportunities Fund, LP.
Shares: 262,055.00 · Class: 0.54%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001172661-26-000719
- Form type
- SCHEDULE 13G/A
- Filer
- Deep Track Capital, LP
- CIK
- CIK 1856083
- Filed
- Feb 13, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership